Sub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight

Peptides

Volumn 32, Issue 5, 2011, Pages 938-945

  Szalowska, Ewa ^a,b   Meijer, Kees ^a   Kloosterhuis, Niels ^a   Razaee, Farhad ^a   Priebe, Marion ^a   Vonk, Roel J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Adipose tissue; GIP; Insulin resistance; Lipid metabolism; Type 2 diabetes

Indexed keywords

CHOLESTEROL; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN LIPASE; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; APO GENE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CYP GENE; DNA MICROARRAY; ENERGY METABOLISM; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCHRONIC DRUG ADMINISTRATION; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; GASTRIC INHIBITORY POLYPEPTIDE; INSULIN; INTERLEUKIN-6; LIPID METABOLISM; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 79955473601     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.02.011     Document Type: Article

References (31)

1. C.X. Andersson, B. Gustafson, A. Hammarstedt, S. Hedjazifar, and U. Smith Inflamed adipose tissue, insulin resistance and vascular injury Diabetes Metab Res Rev 24 2008 595 603
2. M. Asmar, and J.J. Holst Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances Curr Opin Endocrinol Diabetes Obes 17 2010 57 62
3. M.K. Badman, and J.S. Flier The gut and energy balance: visceral allies in the obesity wars Science 307 2005 1909 1914 (Pubitemid 40404693)
4. J.P. Bastard, M. Maachi, C. Lagathu, M.J. Kim, M. Caron, and H. Vidal Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur Cytokine Netw 17 2006 4 12
5. Y. Cao Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases Nat Rev Drug Discov 9 2010 107 115
6. H. Doege, and A. Stahl Protein-mediated fatty acid uptake: novel insights from in vivo models Physiology (Bethesda) 21 2006 259 268 (Pubitemid 44156858)
7. J.B. Flowers, A.T. Oler, S.T. Nadler, Y. Choi, K.L. Schueler, and B.S. Yandell Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance Am J Physiol Endocrinol Metab 292 2007 E936 E945
8. V.A. Fonseca, B. Zinman, M.A. Nauck, A.B. Goldfine, and J. Plutzky Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies Am J Med 123 2010 S2 S10
9. S. Gu, C.J. Villegas, and J.X. Jiang Differential regulation of amino acid transporter SNAT3 by insulin in hepatocytes J Biol Chem 280 2005 26055 26062 (Pubitemid 41022197)
10. T. Hansotia, A. Maida, G. Flock, Y. Yamada, K. Tsukiyama, and Y. Seino Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure J Clin Invest 117 2007 143 152 (Pubitemid 46048461)
11. S.A. Hinke, R.W. Gelling, R.A. Pederson, S. Manhart, C. Nian, and H.U. Demuth Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats Diabetes 51 2002 652 661 (Pubitemid 34760172)
12. E. Kim, K. Li, C. Lieu, S. Tong, S. Kawai, and T. Fukutomi Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis J Hepatol 49 2008 787 798
13. S.J. Kim, C. Nian, and C.H. McIntosh Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes J Biol Chem 282 2007 34139 34147 (Pubitemid 350159458)
14. S.J. Kim, C. Nian, and C.H. McIntosh Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade J Biol Chem 282 2007 8557 8567 (Pubitemid 47093503)
15. T. Korenaga, X. Fu, Y. Xing, T. Matsusita, K. Kuramoto, and S. Syumiya Tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils Am J Pathol 164 2004 1597 1606 (Pubitemid 38529762)
16. J.K. Kruit, A.L. Drayer, V.W. Bloks, N. Blom, S.G. Olthof, and P.J. Sauer Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia J Biol Chem 283 2008 6281 6287
17. W.R. Lagor, R.J. Brown, S.A. Toh, J.S. Millar, I.V. Fuki, and M. de ls Llera-Moya Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo Arterioscler Thromb Vasc Biol 29 2009 40 46
18. B.J. Lamont, and D.J. Drucker Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice Diabetes 57 1 (January) 2008 190 198
19. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
20. K. Miyawaki, Y. Yamada, N. Ban, Y. Ihara, K. Tsukiyama, and H. Zhou Inhibition of gastric inhibitory polypeptide signaling prevents obesity Nat Med 8 2002 738 742 (Pubitemid 34778728)
21. M.J. Oudhoff, J.G. Bolscher, K. Nazmi, H. Kalay, W. van't Hof, and A.V. Amerongen Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay FASEB J 22 2008 3805 3812
22. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
23. P.R. Provost, E. Boucher, and Y. Tremblay Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids J Endocrinol 200 2009 321 330
24. J. Sawashita, F. Kametani, K. Hasegawa, S. Tsutsumi-Yasuhara, B. Zhang, and J. Yan Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II Biochim Biophys Acta 1794 2009 1517 1529
25. Y. Shu, S.A. Sheardown, C. Brown, R.P. Owen, S. Zhang, and R.A. Castro Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action J Clin Invest 117 2007 1422 1431 (Pubitemid 46718430)
26. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, and C.M. Wright The hormone resistin links obesity to diabetes Nature 409 2001 307 312 (Pubitemid 32151228)
27. Y. Takahashi, J. Inoue, H. Kagechika, and R. Sato ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists FEBS Lett 583 2009 493 497
28. J. Wada Vaspin: a novel serpin with insulin-sensitizing effects Expert Opin Investig Drugs 17 2008 327 333 (Pubitemid 351578185)
29. H. Wang, and R.H. Eckel Lipoprotein lipase: from gene to obesity Am J Physiol Endocrinol Metab 297 2009 E271 E288
30. X. Yang, B. Zhang, C. Molony, E. Chudin, K. Hao, and J. Zhu Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver Genome Res 20 2010 1020 1036
31. K.H. Yoo, Y.N. Kim, M.J. Lee, J.K. Seong, and J.H. Park Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse Proteomics 9 2009 3824 3832